Who is sponsoring NCT03668002?

NCT03668002 is sponsored by University of Pittsburgh.

What condition does NCT03668002 study?

NCT03668002 studies End Stage Renal Disease, Arteriovenous Fistula, Arteriovenous Graft.

What drugs are being tested in NCT03668002?

Interventions: Arteriovenous Fistula (AVF), Arteriovenous Graft (AVG).

What is the status of NCT03668002?

NCT03668002 is currently TERMINATED.

Last reviewed 2023-08-14 · How we verify

Trial of Fistula Versus Graft in Elderly Patients

NCT03668002 NA TERMINATED

This open-label pilot randomized controlled trial will test the feasibility and safety of randomizing patients over 65 years old who start hemodialysis with a tunneled dialysis catheter (TDC), and are eligible to receive either arteriovenous fistula (AVF) or arteriovenous graft (AVG), to an AVF strategy (comparator) or to an AVG strategy (intervention). The primary outcome is feasibility, which we will assess by measuring: (1) the proportion of randomized participants who receive the assigned arteriovenous access; and (2) the annual rate of enrollment in the study, accounting for the number of surgeons who participate. Secondary outcomes will include perioperative morbidity and mortality, catheter removal rates, additional procedures performed, and the reasons a patient may not receive the assigned AV access.

Details

Lead sponsor	University of Pittsburgh
Phase	NA
Status	TERMINATED
Enrolment	21
Start date	Fri Sep 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Aug 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

End Stage Renal Disease
Arteriovenous Fistula
Arteriovenous Graft

Interventions

Arteriovenous Fistula (AVF)
Arteriovenous Graft (AVG)

Countries

United States